RNV-1001 selected as the national new drug development project by KDDF*
* KDDF (The Korea Drug Development Fund) is a government funded organization to accelerate innovation activities in Korean pharmaceutical R&D communities. KDDF supports the investment and development of promising drugs.
Initiate Phase 2/3 in the US
Series B Investment($19M)